Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Heidenreich

Showing results (41-50 of 98) with videos related to

Pageof 10
Sort By:
Leukemia|February 24, 2023
Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemiaHasan Issa, Laura E Swart, Milad Rasouli, et al.
Cellular and Molecular Life Sciences : CMLS|February 23, 2023
A RUNX1/ETO-SKP2-CDKN1B axis regulates expression of telomerase in t (8;21) acute myeloid leukemiaEmmanuel J Moses, Adam Azlan, Kang Zi Khor, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 25, 2022
SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformationZivojin Jevtic, Vittoria Matafora, Francesca Casagrande, et al.
Advanced Healthcare Materials|July 21, 2025
Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic DeliveryMohammad Nasrullah, Remant Kc, Amarnath Praphakar Rajendran, et al.
Cancer Cell International|September 15, 2023
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemiaHayden L Bell, Helen J Blair, Mankaran Singh, et al.
Haematologica|March 19, 2026
B-cell precursor acute lymphoblastic leukaemia with <i>IGH::CEBP</i> rearrangement: what have we learnt over the years?Ahlam Alqahtani, Kent T M Fung, Letizia Marchetti, et al.
Hemasphere|October 17, 2025
Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemiaHanna Kirchhoff, Caroline Schoenherr, Lisa Fleischer, et al.
Haematologica|September 16, 2008
Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETOTobias Berg, Manfred Fliegauf, Jan Burger, et al.
European Journal of Medical Genetics|January 4, 2024
Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expressionKristian L Juul-Dam, Neerav N Shukla, Todd M Cooper, et al.
Hemasphere|July 31, 2023
The MLL-Menin Interaction is a Therapeutic Vulnerability in <i>NUP98</i>-rearranged AMLMilad Rasouli, Helen Blair, Selina Troester, et al.
Pageof 10

Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Leukemia|February 24, 2023
Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemiaHasan Issa, Laura E Swart, Milad Rasouli, et al.
Cellular and Molecular Life Sciences : CMLS|February 23, 2023
A RUNX1/ETO-SKP2-CDKN1B axis regulates expression of telomerase in t (8;21) acute myeloid leukemiaEmmanuel J Moses, Adam Azlan, Kang Zi Khor, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 25, 2022
SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformationZivojin Jevtic, Vittoria Matafora, Francesca Casagrande, et al.
Advanced Healthcare Materials|July 21, 2025
Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic DeliveryMohammad Nasrullah, Remant Kc, Amarnath Praphakar Rajendran, et al.
Cancer Cell International|September 15, 2023
Targeting WEE1 kinase as a p53-independent therapeutic strategy in high-risk and relapsed acute lymphoblastic leukemiaHayden L Bell, Helen J Blair, Mankaran Singh, et al.
Haematologica|March 19, 2026
B-cell precursor acute lymphoblastic leukaemia with <i>IGH::CEBP</i> rearrangement: what have we learnt over the years?Ahlam Alqahtani, Kent T M Fung, Letizia Marchetti, et al.
Hemasphere|October 17, 2025
Combination of targeted pharmacotherapy and immunotherapy with anti-CD19 CAR NK cells in acute lymphoblastic leukemiaHanna Kirchhoff, Caroline Schoenherr, Lisa Fleischer, et al.
Haematologica|September 16, 2008
Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETOTobias Berg, Manfred Fliegauf, Jan Burger, et al.
European Journal of Medical Genetics|January 4, 2024
Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expressionKristian L Juul-Dam, Neerav N Shukla, Todd M Cooper, et al.
Hemasphere|July 31, 2023
The MLL-Menin Interaction is a Therapeutic Vulnerability in <i>NUP98</i>-rearranged AMLMilad Rasouli, Helen Blair, Selina Troester, et al.
Pageof 10